Blood Plasma Market – Industry Size, Share & Analysis 2019-2027 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Blood Plasma Market – Industry Size, Share & Analysis 2019-2027

Description:

According to Triton Market Research, the global market for blood plasma is expected to display a positive market trend over the forecast period of 2019-2027, exhibiting a CAGR of 6.13%, Request Free Sample – PowerPoint PPT presentation

Number of Views:11

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Blood Plasma Market – Industry Size, Share & Analysis 2019-2027


1
BLOOD PLASMA MARKET
  • 2019-2027

2
  • According to Triton Market Research, the global
    market for blood plasma is expected to display a
    positive market trend over the forecast period of
    2019-2027, exhibiting a CAGR of 6.13.
  • Plasma, the principal constituent of blood, plays
    a pivotal role in regulating the bodys
    functions. It is composed of various useful
    elements, such as immunoglobulins, coagulation
    factors, albumin and protease inhibitors. Since
    insufficiencies in a component can give rise to
    disease, both basic and targeted research
    development has begun in this field.
  • Blood plasma is part of an effective therapeutic
    plan of treatment in numerous therapies due to
    its potential in combatting several diseases,
    like leukemia, hemophilia, immunodeficiency and
    other bleeding diseases, which are chronic and
    life-threatening.
  • Blood plasma products have proven to be a
    blessing for patients suffering from such
    conditions, which has demanded a more
    comprehensive knowledge of their applications.

MARKET OUTLOOK
3
  • REGIONAL OUTLOOK
  • The global blood plasma market spans across the
    regions of North America, the Middle East and
    Africa, Latin America, Europe and the
    Asia-Pacific.
  • The Asia-Pacific blood plasma market was the
    fastest growing market over the world, in terms
    of CAGR. The APAC region offers extensive
    opportunities for the expansion of the blood
    plasma market.
  • The Asia-Pacific Blood Network (APBN) is a
    non-profit organization with strategic leadership
    policies for the regulation of its members
    activities, in a bid to increase the plasma
    supply across the region. Established in 2006,
    the network aims to provide the safe, steady and
    cost-efficient supply of blood and its
    components.
  • Japan has dominated the Asia-Pacific market due
    to the rise in the number of its organizations
    that ensure the supply of blood plasma. China was
    second in significant contributions to the blood
    plasma market.

4
  • REQUEST FREE SAMPLE!

Global market for blood plasma is expected to
display a positive market trend over the forecast
period of 2019-2027, exhibiting a CAGR of 6.13.
https//www.tritonmarketresearch.com/reports/globa
l-blood-plasma-market
5
INFOGRAPHIC
Request Free Sample _at_ https//www.tritonmarketrese
arch.com/reports/global-blood-plasma-market
6
NORTH AMERICA
Request Free Sample _at_ https//www.tritonmarketrese
arch.com/reports/north-america-blood-plasma-market
7
EUROPE
Request Free Sample _at_ https//www.tritonmarketrese
arch.com/reports/europe-blood-plasma-market
8
ASIA PACIFIC
Request Free Sample _at_ https//www.tritonmarketrese
arch.com/reports/asia-pacific-blood-plasma-market
9
LATIN AMERICA
Request Free Sample _at_ https//www.tritonmarketrese
arch.com/reports/latin-america-blood-plasma-market
10
MIDDLE EAST AFRICA
Request Free Sample _at_ https//www.tritonmarketrese
arch.com/reports/middle-east-and-africa-blood-plas
ma-market
11
  • COMPETITIVE OUTLOOK

The companies that have been mentioned in the
market report are Cerus Corp., General Electric,
Co., China Biologic Products, Inc., ADMA
Biologics, Inc., CSL Ltd., Biotest AG, Grifols
International S.A., Baxter International, Inc.,
Octapharma AG, Arthrex and Shire Plc. Biotest AG
is an international company that supplies plasma
protein biotherapeutic drugs and manufactures
products used in various therapeutic disciplines
including clinical immunology, hematology and
intensive care medicine. The company has achieved
expertise in the production of immunoglobulins,
clotting factors and albumin, along with
monoclonal antibodies used in clinical
development.
12
CONTACT US
UK OFFICE 196, wards wharf approach London E16
2EQ INDIA OFFICE Navjivan CHS Block No.02/08,
S.B.Marg Bhagwansingh Colony, Matunga West Mumbai
MH 400016
13
THANK YOU
About PowerShow.com